# Lifetech Scientific (Shenzhen) Co., Ltd. trials: 44 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 44 trials with Lifetech Scientific (Shenzhen) Co., Ltd. as lead sponsor, 16 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Lifetech Scientific (Shenzhen) Co., Ltd.: 44 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/lifetech-scientific-shenzhen-co-ltd

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 44
- Recruiting or not yet: 16
- Read on: November 19, 2026

## Trials

The 25 newest of 44, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 10, 2026 | NCT07754240 | A Clinical Investigational Study of Ankura™ II AAA, IE and AE Stent Graft System for Endovascular Treatment of Abdominal Aortic Aneurysm | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Abdominal Aortic Aneurysms (AAA) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07754240) |
| June 15, 2026 | NCT07646704 | HeartR™ PDA Occluder Post-Market Follow-Up Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Recruiting | Patent Ductus Arteriosus | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07646704) |
| April 14, 2026 | NCT07529028 | Safety and Efficacy of the AbsnowTM II Absorbable Atrial Septal Defect Closure System for Atrial Septal Defect Closure Therapy | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Not yet recruiting | Atrial Septal Defect | 236 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07529028) |
| February 4, 2026 | NCT07385599 | FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Non-valvular Atrial Fibrillation (NVAF) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385599) |
| April 8, 2025 | NCT06915545 | Study on the Aortic Arch Single Branch Stent Graft System | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Aortic Dissection | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06915545) |
| February 27, 2025 | NCT06849635 | Cera™ ASD Occluder Post-Market Clinical Follow-Up Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Recruiting | Atrial Septal Defect | 139 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06849635) |
| November 29, 2024 | NCT06710938 | Thoracoabdominal Artery Stent Graft System Exploratory Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Thoracoabdominal Aortic Aneurysms | 11 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06710938) |
| November 21, 2024 | NCT06700174 | Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Recruiting | Atrial Septal Defect (ASD) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06700174) |
| October 28, 2024 | NCT06660927 | The Study on the Safety and Efficacy of the G-iliac Iliac Bifurcation Stent Graft System | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Unknown | Common Iliac Artery Aneurysm | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06660927) |
| July 25, 2024 | NCT06520774 | Concave Supra-arch Branched Stent-Graft System for Endovascular Treatment of Aortic Arch Diseases | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Aortic Arch Aneurysm, Penetrating Aortic Ulcer | 103 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06520774) |
| June 27, 2024 | NCT06478576 | Study on Multibranched Stent Graft System in the Treatment of Thoracoabdominal Aortic Aneurysm | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Thoracoabdominal Aortic Aneurysm | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06478576) |
| November 7, 2023 | NCT06120270 | CeraFlex PFO Closure System PMCF Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Recruiting | Patent Foramen Ovale | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06120270) |
| October 25, 2023 | NCT06099015 | Cera™ Vascular Plug System Post-Market Clinical Follow-Up | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Recruiting | Aneurysm, Endoleak, Pulmonary Arteriovenous Malformation, Portal Hypertension, Arteriovenous Fistula, Splenic Laceration | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06099015) |
| June 8, 2023 | NCT05893758 | Lifetech Cera™ PFO Occluder Post-Market Clinical Follow-Up | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Completed | Patent Foramen Ovale, PFO | 94 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05893758) |
| June 5, 2023 | NCT05887700 | Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Active not recruiting | Atrial Septal Defect | 145 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05887700) |
| May 18, 2023 | NCT05864560 | Ankura™ AAA, Cuff and AUI Stent Graft System Post-Market Clinical Follow-Up | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Active not recruiting | Abdominal Aortic Aneurysm | 164 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05864560) |
| April 7, 2023 | NCT05803564 | Thoracoabdominal Aortic Stent System for Endovascular Treatment of Thoracoabdominal Aortic Dissecting Aneurysm. | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Thoracoabdominal; Aortic, Aneurysm, Dissecting | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05803564) |
| March 17, 2023 | NCT05774288 | Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Patent Foramen Ovale, Cryptogenic Stroke | 244 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05774288) |
| December 6, 2022 | NCT05639569 | Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Active not recruiting | Aneurysm Thoracic, Dissection of Thoracic Aorta | 147 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05639569) |
| April 5, 2022 | NCT05312554 | Safety and Efficacy of IrisFIT™ Patent Foramen Ovale Occluders | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Withdrawn | Patent Foramen Ovale, Cryptogenic Stroke | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05312554) |
| November 19, 2021 | NCT05126446 | the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Active not recruiting | Aortic Dissection | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05126446) |
| September 23, 2021 | NCT05054985 | Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm. | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Recruiting | Thoracoabdominal Aortic Aneurysms | 73 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05054985) |
| February 1, 2021 | NCT04731636 | Guo's Visceral Arteries Reconstruction: First in Man Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Not applicable | Completed | Thoracoabdominal Aortic Aneurysm, Pararenal Aortic Aneurysm | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04731636) |
| September 22, 2020 | NCT04559243 | Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Recruiting | Non-valvular Atrial Fibrillation, Embolic Stroke | 579 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04559243) |
| June 5, 2020 | NCT04417712 | Lifetech KONAR MFO Post-Market Clinical Follow-Up Study | Lifetech Scientific (Shenzhen) Co., Ltd. | Observational | Completed | Ventricular Septal Defect | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04417712) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 3 | 1 |
| Not applicable | 28 |
| Observational | 14 |

## By status

| Status | Trials |
| --- | --- |
| Recruiting | 15 |
| Unknown | 12 |
| Completed | 11 |
| Active not recruiting | 4 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Heart Septal Defects, Atrial | 6 |
| Atrial Fibrillation | 6 |
| Foramen Ovale, Patent | 6 |
| Aortic Aneurysm, Thoracoabdominal | 4 |
| Aortic Aneurysm, Abdominal | 3 |
| Aortic Dissection | 3 |
| Ductus Arteriosus, Patent | 3 |
| Ischemic Stroke | 3 |
| Aneurysm | 2 |
| Dissection, Thoracic Aorta | 2 |
| Embolic Stroke | 1 |
| Aortic Aneurysm, Thoracic | 1 |
| Heart Septal Defects, Ventricular | 1 |
| Emphysema | 1 |
| Aneurysm, Aortic Arch | 1 |
| Penetrating Atherosclerotic Ulcer | 1 |
| Venous Thromboembolism | 1 |
| Iliac Aneurysm | 1 |
| Endoleak | 1 |
| Pulmonary Arteriovenous Fistulas | 1 |
| Hypertension, Portal | 1 |
| Arteriovenous Fistula | 1 |
| Stroke | 1 |
| Thrombosis | 1 |
| Aortic Diseases | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Allergy and immunology practices in the United States](https://specstream.ai/data/businesses/allergy-and-immunology-practices/united-states)
- [Fondue restaurants in the United States](https://specstream.ai/data/businesses/fondue-restaurants/united-states)
- [Public relations firms in the United States](https://specstream.ai/data/businesses/public-relations-firms/united-states)
- [Billing services in the United States](https://specstream.ai/data/businesses/billing-services/united-states)
- [Instrumentation engineers in the United States](https://specstream.ai/data/businesses/instrumentation-engineers/united-states)
- [Surgical supply companies in the United States](https://specstream.ai/data/businesses/surgical-supply-companies/united-states)
